{
  "company_number": "09966444",
  "name": "Guardian Pharmaceuticals Co Ltd",
  "url": "/company/09966444",
  "status": "dissolved",
  "is_active": false,
  "company_type": "ltd",
  "incorporated_on": "2016-01-25",
  "dissolved_on": "2025-02-11",
  "sic_codes": [
    {
      "code": "46460",
      "description": "Wholesale of pharmaceutical goods",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/46460"
    },
    {
      "code": "47730",
      "description": "Dispensing chemist in specialised stores",
      "section": "G",
      "section_name": "Wholesale and retail trade; repair of motor vehicles and motorcycles",
      "url": "/sic/47730"
    }
  ],
  "registered_address": {
    "id": 450331,
    "url": "/address/450331",
    "line1": "4 HAWTHORNE AVENUE",
    "line2": "",
    "post_town": "NANTWICH",
    "county": "",
    "country": "ENGLAND",
    "postcode": "CW5 6HZ"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09966444",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "",
  "accounts": {
    "next_due": null,
    "last_made_up": null,
    "category": "",
    "filings": [
      {
        "url": "/company/09966444/accounts/2023-01-27",
        "pdf_url": "/company/09966444/accounts/2023-01-27.pdf",
        "made_up_date": "2023-01-27",
        "period_start": null,
        "period_end": "2023-01-27",
        "entity_name": "Guardian Pharmaceuticals Co Ltd",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "448.00",
        "debtors": "35400.00",
        "cash_bank_in_hand": "450.00",
        "current_assets": "35850.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-8742.00",
        "total_assets_less_current_liabilities": "-8294.00",
        "net_assets_liabilities": "-8491.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2024.zip"
      },
      {
        "url": "/company/09966444/accounts/2022-01-27",
        "pdf_url": "/company/09966444/accounts/2022-01-27.pdf",
        "made_up_date": "2022-01-27",
        "period_start": null,
        "period_end": "2022-01-27",
        "entity_name": "Guardian Pharmaceuticals Co Ltd",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "841.00",
        "debtors": "442271.00",
        "cash_bank_in_hand": "2974621.00",
        "current_assets": "3416892.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "50983.00",
        "total_assets_less_current_liabilities": "51824.00",
        "net_assets_liabilities": "51627.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2023.zip"
      },
      {
        "url": "/company/09966444/accounts/2021-01-27",
        "pdf_url": "/company/09966444/accounts/2021-01-27.pdf",
        "made_up_date": "2021-01-27",
        "period_start": null,
        "period_end": "2021-01-27",
        "entity_name": "Guardian Pharmaceuticals Co Ltd",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "1037.00",
        "debtors": "120613.00",
        "cash_bank_in_hand": "2256408.00",
        "current_assets": "2524271.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "90853.00",
        "total_assets_less_current_liabilities": "91890.00",
        "net_assets_liabilities": "91693.00",
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-November2021.zip"
      },
      {
        "url": "/company/09966444/accounts/2020-01-28",
        "pdf_url": "/company/09966444/accounts/2020-01-28.pdf",
        "made_up_date": "2020-01-28",
        "period_start": null,
        "period_end": "2020-01-28",
        "entity_name": "Guardian Pharmaceuticals Co Ltd",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "192.00",
        "debtors": "517096.00",
        "cash_bank_in_hand": "1293085.00",
        "current_assets": "1894034.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "61648.00",
        "total_assets_less_current_liabilities": "61840.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2021.zip"
      },
      {
        "url": "/company/09966444/accounts/2019-01-28",
        "pdf_url": "/company/09966444/accounts/2019-01-28.pdf",
        "made_up_date": "2019-01-28",
        "period_start": null,
        "period_end": "2019-01-28",
        "entity_name": "Guardian Pharmaceuticals Co Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "943.00",
        "debtors": "2127180.00",
        "cash_bank_in_hand": "44577.00",
        "current_assets": "2272173.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "7931.00",
        "total_assets_less_current_liabilities": "8874.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-June2021.zip"
      },
      {
        "url": "/company/09966444/accounts/2018-01-30",
        "pdf_url": "/company/09966444/accounts/2018-01-30.pdf",
        "made_up_date": "2018-01-30",
        "period_start": null,
        "period_end": "2018-01-30",
        "entity_name": "Guardian Pharmaceuticals Co Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "1305.00",
        "debtors": null,
        "cash_bank_in_hand": "73763.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-120067.00",
        "total_assets_less_current_liabilities": "-118762.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2018.zip"
      },
      {
        "url": "/company/09966444/accounts/2017-01-30",
        "pdf_url": "/company/09966444/accounts/2017-01-30.pdf",
        "made_up_date": "2017-01-30",
        "period_start": null,
        "period_end": "2017-01-30",
        "entity_name": "Guardian Pharmaceuticals Co Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": null,
        "debtors": null,
        "cash_bank_in_hand": "202767.00",
        "current_assets": null,
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-72983.00",
        "total_assets_less_current_liabilities": "-72983.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "100.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-January2018.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09966444/filing-history"
  },
  "confirmation_statement": {
    "next_due": null,
    "last_made_up": null
  },
  "officers": [],
  "psc": [],
  "external_links": [],
  "provenance": {
    "source": "api",
    "first_seen_at": "2026-11-17T18:18:35.229074+00:00",
    "last_seen_snapshot": null,
    "retrieved_at": "2026-11-17T18:18:35.222967+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}